A study on measurement of KP-103 concentration in nails (Phase I) - Investigation of KP-103 concentration in nails following repeated topical application to toenails in patients with onychomycosis
Not Applicable
- Conditions
- Onychomycosis
- Registration Number
- JPRN-UMIN000001949
- Lead Sponsor
- KAKEN PHARMACEUTICAL CO.,LTD.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Patient on corticosteroid (except external preparation for topical action to areas other than toenails is allowable) (2) Patient with problems in safety
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method KP-103 concentration in nails, onset of adverse effects and their severity
- Secondary Outcome Measures
Name Time Method